Mostrar el registro sencillo del documento

dc.rights.licenseAtribución-NoComercial-SinDerivadas 4.0 Internacional
dc.contributor.advisorMora Pabón, Guillermo
dc.contributor.authorMoreno Socha, Javier Andrés
dc.contributor.otherNavarro Cárdenas, Jaime David
dc.contributor.otherVargas Cáceres, Anamaría
dc.contributor.otherBaquero Galvis, Romar
dc.contributor.otherGonzález Caicedo, Paula
dc.date.accessioned2022-08-11T21:13:33Z
dc.date.available2022-08-11T21:13:33Z
dc.date.issued2022-06-29
dc.identifier.urihttps://repositorio.unal.edu.co/handle/unal/81855
dc.descriptionfotografías, gráficas, ilustraciones, tablas
dc.description.abstractEl Hospital Universitario Nacional de Colombia (HUN), junto a la Universidad Nacional de Colombia, se han posicionado como un centro de referencia asistencial y académica, con proyección a formar clínicas o centros de excelencia; en la búsqueda de este objetivo, es indispensable el desarrollo de estándares clínicos basados en la evidencia (ECBE), que son documentos realizados con la mejor evidencia médica disponible y que permiten una adecuada y estandarizada atención de los pacientes. La enfermedad cardiovascular representa la principal causa de muerte a nivel mundial, y una de las principales en Colombia; la detección temprana de la enfermedad aumenta las oportunidades de tratamiento oportuno, disminuyendo la morbimortalidad y los costos económicos y humanos asociados a esta. En 2019 se atendieron 281 personas con IAM el Hospital Universitario Nacional de Colombia (HUN), para un total de 1742 días de estancia hospitalaria, razón por la cual el IAM se considera una enfermedad de importancia en el hospital. Este ECBE busca Identificar las indicaciones para el diagnóstico y tratamiento de los pacientes con IAM atendidos en el HUN, para facilitar la atención de los pacientes. (Texto tomado de la fuente)
dc.description.abstractThe National University Hospital of Colombia (HUN), together with the National University of Colombia, have positioned themselves as a care and academic reference center, with a projection to form clinics or centers of excellence; In pursuit of this objective, the development of evidence-based clinical standards (ECBE) is essential, which are documents made with the best available medical evidence and that allow adequate and standardized patient care. Cardiovascular disease represents the leading cause of death worldwide and one of the main ones in Colombia; early detection of the disease increases the opportunities for timely treatment, reducing morbidity and mortality and the economic and human costs associated with it. In 2019, 281 people with AMI were treated at the National University Hospital of Colombia (HUN) for a total of 1742 days of hospital stay, which is why AMI is considered a significant disease in the hospital. This ECBE seeks to identify the indications for the diagnosis and treatment of patients with AMI treated at the HUN, to facilitate patient care.
dc.format.extent117 páginas
dc.format.mimetypeapplication/pdf
dc.language.isospa
dc.publisherUniversidad Nacional de Colombia
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.ddc610 - Medicina y salud::616 - Enfermedades
dc.titleEstándar clínico basado en la evidencia: Diagnóstico y tratamiento del paciente con infarto agudo de miocardio en el Hospital Universitario Nacional de Colombia
dc.typeTrabajo de grado - Especialidad Médica
dc.type.driverinfo:eu-repo/semantics/masterThesis
dc.type.versioninfo:eu-repo/semantics/acceptedVersion
dc.publisher.programBogotá - Medicina - Especialidad en Medicina Interna
dc.contributor.projectmemberGaitán Duarte, Hernando
dc.contributor.projectmemberPardo Turriago, Rodrigo
dc.contributor.projectmemberAmaya Nieto, Javier
dc.contributor.projectmemberBuitrago, Giancarlo
dc.contributor.subjectmatterexpertEspinosa Almanza, Carmelo José
dc.contributor.subjectmatterexpertMelendez Rhenals, Sugeich
dc.contributor.subjectmatterexpertBetancourt Pérez, Harold
dc.contributor.subjectmatterexpertQuintero Sacipa, Lorena Marcela
dc.contributor.subjectmatterexpertSánchez Merchán, Ángel Yobany
dc.contributor.subjectmatterexpertRíos, William
dc.contributor.subjectmatterexpertArdila Ardila, Diego José
dc.description.degreelevelEspecialidades Médicas
dc.description.degreenameEspecialista en Medicina Interna
dc.identifier.instnameUniversidad Nacional de Colombia
dc.identifier.reponameRepositorio Institucional Universidad Nacional de Colombia
dc.identifier.repourlhttps://repositorio.unal.edu.co/
dc.publisher.departmentDepartamento de Medicina Interna
dc.publisher.facultyFacultad de Medicina
dc.publisher.placeBogotá, Colombia
dc.publisher.branchUniversidad Nacional de Colombia - Sede Bogotá
dc.relation.referencesIlott I, Rick J, Patterson M, Turgoose C, Lacey A. What is protocol-based care? A concept analysis. J Nurs Manag. 2006;14(7):544-52. doi: 10.1111/j.1365-2934.2006.00703.x.
dc.relation.referencesGulwani S. Programming by examples: Applications, algorithms, and ambiguity resolution.Redmond, WA: Microsoft Corporation; 2016.
dc.relation.referencesIbanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-77. doi: 10.1093/eurheartj/ehx393.
dc.relation.referencesJun GT, Ward J, Morris Z, Clarkson J. Health care process modelling: which method when? International Journal for Quality in Health Care. Int J Qual Health Care. 2009; (3):214-24. doi: 10.1093/intqhc/mzp016.
dc.relation.referencesPage MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71.
dc.relation.referencesThygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018;72(18):2231-2264. doi: 10.1016/j.jacc.2018.08.1038.
dc.relation.referencesCollet J-P, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289-1367. doi: 10.1093/eurheartj/ehaa575.
dc.relation.referencesSwitzerland. World Health Organization (WHO) The top 10 causes of death. [cited April 24 2022]. Geneva: WHO 24 Maggio. 2018. p. 1-7. Available from: https://bit.ly/3MIEBY5.
dc.relation.referencesHernández-Leiva E. Epidemiología del síndrome coronario agudo y la insuficiencia cardiaca en Latinoamérica. Rev Esp Cardiol. 2011;64(Supl 2):34-43. doi: 10.1016/j.recesp.2011.01.022.
dc.relation.referencesScheen AJ. [NAVIGATOR: A trial of prevention of cardiovascular complications and type 2 diabetes with valsartan and/or nateglinide]. Revue medicale de Liege. 2010;65(4):217-23.
dc.relation.referencesSenior J. Síndrome coronario agudo Epidemia reconocida. Acta Med Colomb. 2014;39(2):107-9.
dc.relation.referencesGaviria S, Ramírez A, Alzate M, Contreras H, Jaramillo N, Muñoz MC. Epidemiología del síndrome coronario agudo. Medicina UPB. 2020;39(1):49-56. doi: 10.18566/medupb.v39n1.a08.
dc.relation.referencesEl-Menyar A, Zubaid M, Shehab A, Bulbanat B, AlBustani N, Alenezi F, et al. Prevalence and impact of cardiovascular risk factors among patients presenting with acute coronary syndrome in the middle East. Clin Cardiol. 2011;34(1):51-8. doi: 10.1002/ clc.20873.
dc.relation.referencesAntman E, Bassand JP, Klein W, Magus O, Lopez-Sendon JL, Rydén L, et al. J Am Coll Cardiol. 2000;36(3):959-69.
dc.relation.referencesGrupo de Trabajo de la SEC para el consenso ESC 2018 sobre la cuarta definición universal del infarto de miocardio. Comentarios al consenso ESC 2018 sobre la cuarta definición universal del infarto de miocardio. Rev Esp Cardiol. 2019;72(1):10-5. doi: 10.1016/j.recesp.2018.11.009.
dc.relation.referencesOoi DS, Isotalo PA, Veinot JP. Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology. Clin Chem. 2000;46(3):338-44.
dc.relation.referencesArós F, Loma-Osorio Á, Villa J, López-Bescós L, Cuñat J, Rodríguez E, et al. Efecto de la asociación de bloqueadores beta e inhibidores de la enzima de conversión en la supervivencia al año tras un infarto agudo de miocardio. Resultados del registro PRIAMHO II. Rev Esp Cardiol. 2006;59(4):313-20. doi: 10.1157/13087059.
dc.relation.referencesGalve E, Oristrell G, García-Dorado D. Estatinas en pacientes con síndrome coronario agudo. Más allá de las lipoproteínas de baja densidad. Rev Esp Cardiol. 2015;15(A):28-33. doi: 10.1016/ S1131-3587(15)70122-6.
dc.relation.referencesMassussi M, Scotti A, Lip GYH, Proietti R. Left ventricular thrombosis: new perspectives on an old problem. Eur Heart J Cardiovasc Pharmacother. 2021;7(2):158-67. doi: 10.1093/ehjcvp/ pvaa066.
dc.relation.referencesBrouwers MC, Kerkvliet K, Spithof K. The AGREE reporting checklist: A tool to improve reporting of clinical practice guidelines. BMJ. 2016;352:i1152. doi:10.1136/bmj.i1152.
dc.relation.referencesUnited Kingdom. National Institute for Health and Care Excellence (NICE). Acute coronary syndromes. London: NICE; 2020.
dc.relation.referencesColombia. Ministerio de Salud y Protección Social (Minsalud). Guía de práctica clínica para El Síndrome Coronario Agudo Sistema General de Seguridad Social en Salud – Colombia. Guía Completa GPC-2013-17. 3rd. ed. Bogotá D.C.: Minsalud; 2017.
dc.relation.referencesMexico. Instituto Mexicano del Seguro Social (IMSS). Diagnóstico Y Tratamiento De Síndrome Coronario Agudo Sin Elevación Del Segmento ST - GPC-IMSS-191-18. Mexico D.F.: IMSS; 2018.
dc.relation.referencesScotland. Scottish Intercollegiate Guidelines Network (SIGN). SIGN 148: Acute coronary syndrome: A national guideline. Edinburg: SIGN; 2016.
dc.relation.referencesWong GC, Welsford M, Ainsworth C, Abuzeid W, Fordyce CB, Greene J, et al. 2019 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Guidelines on the Acute Management of ST-Elevation Myocardial Infarction: Focused Update on Regionalization and Reperfusion. Can J Cardiol. 2019;35(2):107-132. doi: 10.1016/j.cjca.2018.11.031.
dc.relation.referencesWildi K, Nelles B, Twerenbold R, Rubini Giménez M, Reichlin T, Singeisen H, et al. Safety and efficacy of the 0 h/3 h protocol for rapid rule out of myocardial infarction. Am Heart J. 2016;181:16- 25. doi: 10.1016/j.ahj.2016.07.013.
dc.relation.referencesBjurman C, Larsson M, Johanson P, Petzold M, Lindahl B, Fu MLX, et al. Small changes in troponin T levels are common in patients with non-ST-segment elevation myocardial infarction and are linked to higher mortality. J Am Coll Cardiol. 2013;62(14):1231- 8. doi: 10.1016/j.jacc.2013.06.050.
dc.relation.referencesFox KAA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van Werf FV, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ. 2006;333(7578):1091. doi: 10.1136/ bmj.38985.646481.55.
dc.relation.referencesElbarouni B, Goodman SG, Yan RT, Welsh RC, Kornder JM, Deyoung JP, et al. Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in Canada. Am Heart J. 2009;158(3):392-9. doi: 10.1016/j.ahj.2009.06.010.
dc.relation.referencesKillip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit: A Two year experience with 250 patients. American Journal of Cardiology. Am J Cardiol. 1967;20(4):457-64. doi: 10.1016/0002-9149(67)90023-9.
dc.relation.referencesKhot UN, Jia G, Moliterno DJ, Lincoff AM, Khot MB, Harrington RA, et al. Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification. JAMA. 2003;290(16):2174-81. doi: 10.1001/jama.290.16.2174.
dc.relation.referencesPLM. ASPIRINA PROTECT - PLM [Internet]. PLM restaurando la salud a través del conocimiento [cited on February 16 2022]. Available from: https://bit.ly/38BXT2y.
dc.relation.referencesPLM. ENOXAPARINA- PLM [Internet]. PLM restaurando la salud a través del conocimiento [cited on February 16, 2022]. Available from: https://bit.ly/3s18KKf.
dc.relation.referencesPLM. ATORVASTATINA - PLM [Internet]. PLM restaurando la salud a través del conocimiento [cited on February 16, 2022]. Available from: https://bit.ly/3MDeRfx.
dc.relation.referencesPLM. METOPROLOL - PLM [Internet]. PLM restaurando la salud a través del conocimiento [cited on February 16, 2022]. Available from: https://bit.ly/3y5oP5u.
dc.relation.referencesKaplan K, Davison R, Parker M, Przybylek J, Teagarden JR, Lesch M. Intravenous nitroglycerin for the treatment of angina at rest unresponsive to standard nitrate therapy. Am J Cardiol. 1983;51(5):694-8. doi: 10.1016/s0002-9149(83)80117-9.
dc.relation.referencesPLM. DINITRATO DE ISOSORBIDE - PLM [Internet]. PLM restaurando la salud a través del conocimiento [cited on February 16, 2022]. Available from: https://bit.ly/3Kt3zJ9 :
dc.relation.referencesPLM. MORFINA- PLM [Internet]. PLM restaurando la salud a través del conocimiento [cited on February 16, 2022]. Available from: https://bit.ly/3MIv038.
dc.relation.referencesPLM. CLOPIDOGREL - PLM [Internet]. PLM restaurando la salud a través del conocimiento. [cited on February 16, 2022]. Available from: https://bit.ly/3EZ6JDs.
dc.relation.referencesLevi A, Kornowski R, Vaduganathan M, Eisen A, Vaknin-Assa H, Abu-Foul S, et al. Incidence, predictors, and outcomes of failed primary percutaneous coronary intervention: a 10-year contemporary experience. Coron Artery Dis. 2014;25(2):145-51. doi: 10.1097/MCA.0000000000000065.
dc.relation.referencesDubey G, Verma SK, Bahl VK. Primary percutaneous coronary intervention for acute ST elevation myocardial infarction: Outcomes and determinants of outcomes: A tertiary care center study from North India. Indian Heart J. 2017;69(3):294-8. doi: 10.1016/j.ihj.2016.11.322.
dc.relation.referencesTatli E, Alicik G, Buturak A, Yilmaztepe M, Aktoz M. Arrhythmias following Revascularization Procedures in the Course of Acute Myocardial Infarction: Are They Indicators of Reperfusion or Ongoing Ischemia? ScientificWorldJournal. 2013;2013:160380. doi: 10.1155/2013/160380.
dc.relation.referencesPLM. ENALAPRIL - PLM [Internet]. PLM restaurando la salud a través del conocimiento [cited on February 16, 2022]. Available from: https://bit.ly/37SbjY4.
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.subject.proposalDiagnostico
dc.subject.proposalTratamiento
dc.subject.proposalinfarto agudo del miocardio
dc.subject.proposalAdult
dc.subject.proposalMyocardial infarction
dc.subject.proposalCardiovascular stroke
dc.subject.proposalHeart attack
dc.subject.proposalDiagnosis
dc.subject.proposalTherapeutics
dc.subject.proposalSindrome coronario agudo
dc.subject.proposalEstándar clínico
dc.subject.proposalInfarto
dc.title.translatedEvidence-based clinical standard: Diagnosis and treatment of patients with acute myocardial infarction at the National University Hospital of Colombia
dc.type.coarhttp://purl.org/coar/resource_type/c_bdcc
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aa
dc.type.contentText
dc.type.redcolhttp://purl.org/redcol/resource_type/TM
oaire.accessrightshttp://purl.org/coar/access_right/c_abf2
dcterms.audience.professionaldevelopmentInvestigadores
dcterms.audience.professionaldevelopmentMaestros


Archivos en el documento

Thumbnail

Este documento aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del documento

Atribución-NoComercial-SinDerivadas 4.0 InternacionalEsta obra está bajo licencia internacional Creative Commons Reconocimiento-NoComercial 4.0.Este documento ha sido depositado por parte de el(los) autor(es) bajo la siguiente constancia de depósito